Masanori Oshi et al. indicated that in triple-negative breast cancer (TNBC), CD8+ T cells are an essential component of the tumor immune microenvironment (TIME), and their high scores are linked to a better survival rate [38]. This evidence concerns the gene CD8A and triple-negative breast carcinoma.